Viracta Therapeutics, Inc. Quarterly Return On Assets in % from Q1 2012 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Viracta Therapeutics, Inc. quarterly/annual Return On Assets history and growth rate from Q1 2012 to Q3 2024.
  • Viracta Therapeutics, Inc. Return On Assets for the quarter ending September 30, 2024 was -114 %, a 95.3% decline year-over-year.
  • Viracta Therapeutics, Inc. annual Return On Assets for 2023 was -71.5 %, a 32.8% decline from 2022.
  • Viracta Therapeutics, Inc. annual Return On Assets for 2022 was -53.8 %, a 42.6% increase from 2021.
  • Viracta Therapeutics, Inc. annual Return On Assets for 2021 was -93.7 %, a 64.2% decline from 2020.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -114 -55.9 -95.3% Jul 1, 2024 Sep 30, 2024
Q2 2024 -92.6 -30.7 -49.6% Apr 1, 2024 Jun 30, 2024
Q1 2024 -79.6 -21.9 -38.1% Jan 1, 2024 Mar 31, 2024
Q4 2023 -71.5 -17.7 -32.8% Oct 1, 2023 Dec 31, 2023
Q3 2023 -58.6 -5.39 -10.1% Jul 1, 2023 Sep 30, 2023
Q2 2023 -61.9 -15.9 -34.5% Apr 1, 2023 Jun 30, 2023
Q1 2023 -57.6 -16.9 -41.3% Jan 1, 2023 Mar 31, 2023
Q4 2022 -53.8 +39.9 +42.6% Oct 1, 2022 Dec 31, 2022
Q3 2022 -53.2 +48.8 +47.8% Jul 1, 2022 Sep 30, 2022
Q2 2022 -46 +69.7 +60.2% Apr 1, 2022 Jun 30, 2022
Q1 2022 -40.8 +117 +74.1% Jan 1, 2022 Mar 31, 2022
Q4 2021 -93.7 -36.6 -64.2% Oct 1, 2021 Dec 31, 2021
Q3 2021 -102 -70.1 -220% Jul 1, 2021 Sep 30, 2021
Q2 2021 -116 -81.2 -235% Apr 1, 2021 Jun 30, 2021
Q1 2021 -158 -115 -266% Jan 1, 2021 Mar 31, 2021
Q4 2020 -57.1 -7.23 -14.5% Oct 1, 2020 Dec 31, 2020
Q3 2020 -31.9 +59.1 +64.9% Jul 1, 2020 Sep 30, 2020
Q2 2020 -34.6 +80.3 +69.9% Apr 1, 2020 Jun 30, 2020
Q1 2020 -43.1 +73.3 +63% Jan 1, 2020 Mar 31, 2020
Q4 2019 -49.8 +74.1 +59.8% Oct 1, 2019 Dec 31, 2019
Q3 2019 -91 +12.9 +12.4% Jul 1, 2019 Sep 30, 2019
Q2 2019 -115 +10.8 +8.56% Apr 1, 2019 Jun 30, 2019
Q1 2019 -116 +13.6 +10.5% Jan 1, 2019 Mar 31, 2019
Q4 2018 -124 +4.79 +3.72% Oct 1, 2018 Dec 31, 2018
Q3 2018 -104 +21.7 +17.3% Jul 1, 2018 Sep 30, 2018
Q2 2018 -126 -13.6 -12.1% Apr 1, 2018 Jun 30, 2018
Q1 2018 -130 -20.6 -18.8% Jan 1, 2018 Mar 31, 2018
Q4 2017 -129 -22.4 -21% Oct 1, 2017 Dec 31, 2017
Q3 2017 -126 -13.6 -12.2% Jul 1, 2017 Sep 30, 2017
Q2 2017 -112 -9.72 -9.5% Apr 1, 2017 Jun 30, 2017
Q1 2017 -109 -15.1 -16.1% Jan 1, 2017 Mar 31, 2017
Q4 2016 -106 -14.9 -16.2% Oct 1, 2016 Dec 31, 2016
Q3 2016 -112 -44.8 -66.9% Jul 1, 2016 Sep 30, 2016
Q2 2016 -102 -21.7 -26.9% Apr 1, 2016 Jun 30, 2016
Q1 2016 -94.2 -15.7 -20% Jan 1, 2016 Mar 31, 2016
Q4 2015 -91.5 -14 -18% Oct 1, 2015 Dec 31, 2015
Q3 2015 -67.1 +22.5 +25.2% Jul 1, 2015 Sep 30, 2015
Q2 2015 -80.6 -5.33 -7.08% Apr 1, 2015 Jun 30, 2015
Q1 2015 -78.5 -6.85 -9.56% Jan 1, 2015 Mar 31, 2015
Q4 2014 -77.5 -8.34 -12.1% Oct 1, 2014 Dec 31, 2014
Q3 2014 -89.6 -35.5 -65.5% Jul 1, 2014 Sep 30, 2014
Q2 2014 -75.3 -12.8 -20.5% Mar 31, 2014 Jun 30, 2014
Q1 2014 -71.7 -3.59 -5.27% Jan 1, 2014 Mar 31, 2014
Q4 2013 -69.2 +11 +13.7% Oct 1, 2013 Dec 31, 2013
Q3 2013 -54.2 +47.1 +46.5% Jul 1, 2013 Sep 30, 2013
Q2 2013 -62.4 +29.6 +32.2% Apr 1, 2013 Jun 30, 2013
Q1 2013 -68.1 +13.1 +16.1% Jan 1, 2013 Mar 31, 2013
Q4 2012 -80.2 Oct 1, 2012 Dec 31, 2012
Q3 2012 -101 Jul 1, 2012 Sep 30, 2012
Q2 2012 -92.1 Apr 1, 2012 Jun 30, 2012
Q1 2012 -81.2 Jan 1, 2012 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.